Novonesis (Novozymes) B
NSISBC
Kedudukan dalam Saham
#1153
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Harga Saham
$70.19
Modal Pasaran
$19.51B
Perubahan (1 hari)
0.13%
Perubahan (1 tahun)
10.71%
Negara
DK
Perdagangan Novonesis (Novozymes) B (NSISBC)
Kategori
Basic Materials
Sejarah harga saham bagi Novonesis (Novozymes) B (NSISBC)
Harga penutupan tertinggi: $69.75 pada 2026-10-01
Harga penutupan terendah: $58.74 pada 2024-03-01
Harga penutupan terendah: $58.74 pada 2024-03-01
Sejarah harga saham Novonesis (Novozymes) B dari 2024 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 1.88% |
| 2025 | 7.42% |
| 2024 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $498.80 | 10.86% |
GB
|
|
| $193.41 | 6.27% |
FR
|
|
| $337.21 | 1.02% |
US
|
|
| $287.77 | 4.26% |
US
|
|
| $302.56 | 19.52% |
US
|
